Kiora Pharmaceuticals (KPRX) Operating Leases (2019 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Operating Leases came in at $373586.0 in Q1 2026, up 327.1% YoY from $87470.0 in Q1 2025, and up 83.31% on a QoQ basis from $203798.0 in Q4 2025.
Kiora Pharmaceuticals (KPRX) Operating Leases (2019 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 8 years of Operating Leases data on file, last reported at $373586.0 in Q1 2026.
- Quarterly Operating Leases rose 327.1% year-over-year to $373586.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $373586.0 (up 327.1% YoY) and the FY2025 annual result came in at $203798.0, up 502.69% from the prior year.
- Operating Leases rose to $373586.0 in Q1 2026, from $203798.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $430405.0 in Q2 2025 to a low of $4764.0 in Q3 2022.
- A 5-year average of $131862.6 and a median of $65992.0 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases slumped 95.84% — and 2025, when it soared 970.74%.
- Tracing KPRX's Operating Leases over 5 years: stood at $4764.0 in 2022, then jumped by 1155.71% to $59822.0 in 2023, then tumbled by 43.47% to $33815.0 in 2024, then jumped by 502.69% to $203798.0 in 2025, then jumped by 83.31% to $373586.0 in 2026.
- The last three Operating Leases figures came in at $373586.0 (Q1 2026), $203798.0 (Q4 2025), and $404165.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 333,022.00 |
| Mar 31, 2026 | 373,586.00 |
| Dec 31, 2025 | 203,798.00 |
| Sep 30, 2025 | 404,165.00 |
| Jun 30, 2025 | 430,405.00 |
| Mar 31, 2025 | 87,470.00 |
| Dec 31, 2024 | 33,815.00 |
| Sep 30, 2024 | 39,190.00 |
| Jun 30, 2024 | 40,197.00 |
| Mar 31, 2024 | 94,299.00 |
| Dec 31, 2023 | 59,822.00 |
| Jun 30, 2023 | 39,009.00 |
| Mar 31, 2023 | 73,289.00 |
| Sep 30, 2022 | 4,764.00 |
| Jun 30, 2022 | 28,138.00 |
| Mar 31, 2022 | 65,992.00 |
| Dec 31, 2021 | 90,566.00 |
| Sep 30, 2021 | 114,475.00 |
| Jun 30, 2021 | 137,957.00 |
| Mar 31, 2021 | 159,938.00 |